Propanc Reports Over 90% Tumor Growth Inhibition and Survival Benefit for PRP in Pancreatic Cancer Models

Lead candidate PRP demonstrated strong tumor control, reduced metastatic spread, and a 2.5-fold increase in survival in preclinical pancreatic cancer studies.